`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`
`COALITION FOR AFFORDABLE DRUGS II LLC
`Petitioner
`
`v.
`
`
`
`NPS PHARMACEUTICALS, INC.
`Patent Owner
`
`_____________________
`
`Case Nos. IPR2015-00990 and IPR2015-01093
`Patent No. 7,056,886
`_____________________
`
`DECLARATION OF CHRISTOPHER E. KIRKPATRICK
`
`
`
`
`
`
`
`
`
`
`
`
`
`Page 1
`
`NPS EX. 2033
`CFAD v. NPS
`IPR2015-01093
`
`
`
`
`
`I, Christopher E. Kirkpatrick, hereby declare the following:
`
`1.
`
`I am the custodian of documents for the Coalition for Affordable
`
`Drugs II LLC (CFAD), which is the Petitioner in Case Nos. IPR2015-00990 and
`
`IPR2015-01093. I am also the General Counsel of Hayman Capital Management,
`
`L.P., which is identified as a real party-in-interest in the same proceedings. As part
`
`of my responsibilities in these positions, I am aware of the persons or entities that
`
`have the ability to control the business actions of CFAD.
`
`2.
`
`I am authorized to provide this declaration as a representative of
`
`CFAD, J Kyle Bass and the “Hayman RPI,” which consist of Hayman Credes
`
`Master Fund, L.P., Hayman Orange Fund SPC – Portfolio A, Hayman Capital
`
`Master Fund, L.P., Hayman Capital Management, L.P., Hayman Offshore
`
`Management, Inc. and Hayman Investments, L.L.C., collectively.
`
`3.
`
`I understand that Petitioner made the following statement with respect
`
`to real parties-in-interest in these proceedings:
`
`Pursuant to 37 C.F.R. § 42.8(b)(1), Petitioner certifies that
`Coalition For Affordable Drugs II LLC (“CFAD”), Hayman
`Credes Master Fund, L.P. (“Credes”), Hayman Orange Fund
`SPC – Portfolio A (“HOF”), Hayman Capital Master Fund, L.P.
`(“HCMF”), Hayman Capital Management, L.P. (“HCM”),
`Hayman Offshore Management, Inc. (“HOM”), Hayman
`Investments, L.L.C. (“HI”), nXn Partners, LLC (“nXnP”), IP
`Navigation Group, LLC (“IPNav”), J Kyle Bass, and Erich
`Spangenberg are the real parties in interest (collectively,
`“RPI”). The RPI hereby certify the following information:
`CFAD is a wholly owned subsidiary of Credes. Credes is a
`limited partnership. HOF is a segregated portfolio company.
`
`
`
`1
`
`Page 2
`
`
`
`
`
`HCMF is a limited partnership. HCM is the general partner and
`investment manager of Credes and HCMF. HCM is the
`investment manager of HOF. HOM is the administrative
`general partner of Credes and HCMF. HI is the general partner
`of HCM. J Kyle Bass is the sole member of HI and sole
`shareholder of HOM. CFAD, Credes, HOF and HCMF act,
`directly or indirectly, through HCM as the general partner
`and/or investment manager of Credes, HOF and HCMF. nXnP
`is a paid consultant to HCM. Erich Spangenberg is 98.5%
`member of nXnP. IPNav is a paid consultant to nXnP. Erich
`Spangenberg is the 98.5% member of IPNav. Other than HCM
`and J Kyle Bass in his capacity as the Chief Investment Officer
`of HCM and nXnP and Erich Spangenberg in his capacity as
`the Manager/CEO of nXnP, no other person (including any
`investor, limited partner, or member or any other person in any
`of CFAD, Credes, HOF, HCMF, HCM, HOM, HI, nXnP or
`IPNav) has authority to direct or control (i) the timing of, filing
`of, content of, or any decisions or other activities relating to this
`Petition or (ii) any timing, future filings, content of, or any
`decisions or other activities relating to the future proceedings
`related to this Petition. All of the costs associated with this
`Petition will be borne by HCM, CFAD, Credes, HOF and/or
`HCMF.
`
`
`IPR2015-00990, Paper 1 at pp. 3-5; IPR2015-01093, Paper 1 at pp. 3-4.
`
`4.
`
`I further understand that, in response to a motion for Additional
`
`Discovery from the Patent Owner NPS Pharmaceuticals, Inc., the Board ordered as
`
`follows:
`
`In particular, as to Request for Production No. 6, we
`authorize additional discovery only as to any agreements,
`in the possession of Petitioner, relating to the control or
`ability to control any aspect of the current proceeding by
`a party not designated as Petitioner or a real party-in-
`interest in the Petition. Such agreements include those
`indicating that any person or party (other than Petitioner
`or designated real parties-in-interest) provided direction
`
`
`
`2
`
`Page 3
`
`
`
`
`
`to, or had the authority to provide direction to, Petitioner
`or its counsel in relation to this proceeding, including
`persons or parties who reviewed, or were given the
`opportunity to review, papers filed in this proceeding.
`
`IPR2015-00990, Paper 14 at p. 7; IPR2015-01093, Paper 14 at p. 7.
`
`
`5.
`
`In response to this Order and at the request of Petitioner, I conducted a
`
`diligent search for any agreements in the possession of CFAD, the Hayman RPI or
`
`J Kyle Bass “relating to the control or ability to control any aspect of the current
`
`proceeding[s] by a party not designated as Petitioner or a real party-in-interest in
`
`the Petition[s].” I located no agreements in the possession of CFAD, the Hayman
`
`RPI or J Kyle Bass that meet this definition.
`
`6.
`
`Further, my search located no agreements in the possession of CFAD,
`
`the Hayman RPI or J Kyle Bass “indicating that any person or party (other than
`
`Petitioner or designated real parties-in-interest) provided direction to, or had the
`
`authority to provide direction to, Petitioner or its counsel in relation to th[ese]
`
`proceeding[s].”
`
`7.
`
`The fact that my search did not locate documents responsive to the
`
`Board’s Order comports with CFAD’s identification of the real parties-in-interest
`
`in its Petitions. As stated in the Petitions, only CFAD, Hayman Capital
`
`Management, L.P., J Kyle Bass, nXn Partners, LLC and Erich Spangenberg have
`
`“authority to direct or control (i) the timing of, filing of, content of, or any
`
`decisions or other activities relating to this Petition or (ii) any timing, future filings,
`
`
`
`3
`
`Page 4
`
`
`
`
`
`content of, or any decisions or other activities relating to the future proceedings
`
`related to th[ese] Petition[s].” IPR2015-00990, Paper 1 at pp. 4-5; IPR2015-
`
`01093, Paper 1 at p. 4. There is no person or party who reviewed, or was given the
`
`opportunity to review, papers filed in these proceedings, who provided direction to,
`
`or had the authority to provide direction to, Petitioner or its counsel (other than the
`
`Petitioner or designated real parties-in-interest, or their employees and counsel).
`
`8.
`
`In addition, only certain of the designated real parties-in-interest
`
`(CFAD, Hayman Capital Management, L.P., Hayman Credes Master Fund, L.P.,
`
`Hayman Orange Fund SPC – Portfolio A and Hayman Capital Master Fund, L.P.)
`
`are funding the costs for these proceedings. No one other than these designated
`
`real parties-in-interest is funding the costs for these proceedings.
`
`9. Moreover, the counsel who file the papers in these proceedings on
`
`behalf of CFAD are given instructions only by CFAD, Hayman Capital
`
`Management, L.P. (or its employees), J Kyle Bass, nXn Partners, LLC (or its
`
`employees) or Erich Spangenberg.
`
`
`
`Date: July 16, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`____________________________________
`Christopher E. Kirkpatrick
`
`
`
`4
`
`Page 5